1. Summary Information
|
|
|
Country |
India |
|
Company Name |
LABORATE PHARMACEUTICALS INDIA LIMITED
|
Principal Name 1 |
Mr. Ajay Bhatia |
|
Status |
Good |
Principal Name 2 |
Mr. Aditya Bhatia |
|
|
|
Registration # |
05-030835 |
|
Street Address |
E-11, Industrial Area, Panipat – 132103, Haryana, India |
||
|
Established Date |
26.02.1990 |
SIC Code |
-- |
|
Telephone# |
91-180-2650072/ 2651248 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-180-2651072 |
Business Style 2 |
Exporter |
|
Homepage |
Product Name 1 |
Pharmaceutical
Formulations |
|
|
# of employees |
Not Available |
Product Name 2 |
-- |
|
Paid up capital |
Rs.43,367,000/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or relatives of directors -100% |
Banking |
Punjab
National Bank |
|
Public Limited Corp. |
NO |
Business Period |
23 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
Ba
(54) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
-- |
-- |
-- |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
776,072,000 |
Current Liabilities |
876,664,000 |
|
Inventories |
792,975,000 |
Long-term Liabilities |
381,729,000
|
|
Fixed Assets |
321,737,000 |
Other Liabilities |
12,783,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
1,271,176,000 |
|
Invest& other Assets |
12,010,000 |
Retained Earnings |
588,251,000 |
|
|
|
Net Worth |
631,618,000 |
|
Total Assets |
1,902,794,000 |
Total Liab. & Equity |
1,902,794,000 |
|
Total Assets (Previous Year) |
1,895,426,000 |
|
|
|
P/L Statement as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Sales |
2,398,328,000 |
Net Profit |
87,174,000 |
|
Sales(Previous yr) |
2,167,108,000 |
Net Profit(Prev.yr) |
79,591,000 |
MIRA
INFORM REPORT
|
Report Date : |
01.06.2013 |
IDENTIFICATION DETAILS
|
Name : |
LABORATE PHARMACEUTICALS INDIA LIMITED
|
|
|
|
|
Formerly Known
As : |
LABORATE PHARMACEUTICALS INDIA PRIVATE LIMITED |
|
|
|
|
Registered Office
: |
E-11, Industrial Area, Panipat – 132103, Haryana |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
26.02.1990 |
|
|
|
|
Com. Reg. No.: |
05-030835 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.43.367 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239HR1990PLC030835 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
RTKL00914E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACL2998K AAAFD9209L |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and
Exporter of Pharmaceutical Formulations. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (54) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2520000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having a fine track record. It
has achieved better growth in its turnover and profit during 2012. The general financial position is good. Creditworth of the company is
good. Performance capacity seems to be high. Trade relations are reported to
be decent. Business is active. Payments are reported to be usually correct
and as per commitment. The company can be considered good for business dealings at usual
trade terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
BBB+ (Long Term Rating) |
|
Rating Explanation |
Moderate degree of safety and moderate
credit risk. |
|
Date |
November 28, 2012 |
|
Rating Agency Name |
CRISIL |
|
Rating |
A2 (Short Term Rating) |
|
Rating Explanation |
Strong degree of safety and low credit risk |
|
Date |
November 28, 2012 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office/ Factory 1 : |
E-11, Industrial Area, Panipat – 132103, Haryana, India |
|
Tel. No.: |
91-180-2650072/ 2651248/ 2650385/ 2655741/ 2655742/ 4092200 |
|
Fax No.: |
91-180-2651072 |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
|
|
|
Admin Office : |
Plot No.31, Industrial Area, Nariwal Paonta Sahib, |
|
|
|
|
Factory 2 : |
51, Industrial Area, Goandpur, Poanta Sahib, |
|
Mobile No.: |
91-9816035069/ 9816045069 |
|
Fax No.: |
91-1704-225069 |
|
|
|
|
Branch Office : |
E-22, Industrial Area, Panipat – 132103, Haryana, India |
DIRECTORS
As on: 22.09.2012
|
Name : |
Mr. Ajay Bhatia |
|||||||||||||||||||||||||||
|
Designation : |
Whole Time Director |
|||||||||||||||||||||||||||
|
Address : |
584, Model Town, Panipat – 132103, Haryana, India |
|||||||||||||||||||||||||||
|
Qualification : |
Graduate |
|||||||||||||||||||||||||||
|
Date of Appointment : |
01.04.2008 |
|||||||||||||||||||||||||||
|
PAN No.: |
ABQPB8284J |
|||||||||||||||||||||||||||
|
DIN No.: |
00038833 |
|||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Name : |
Mr. Aditya Bhatia |
|||||||||||||||||||||||||||
|
Designation : |
Whole-time Director |
|||||||||||||||||||||||||||
|
Address : |
197, Model Town, Panipat – 132103, Haryana, India |
|||||||||||||||||||||||||||
|
Qualification : |
Graduate |
|||||||||||||||||||||||||||
|
Date of Appointment : |
01.04.2004 |
|||||||||||||||||||||||||||
|
PAN No.: |
ADRPB0106A |
|||||||||||||||||||||||||||
|
DIN No.: |
00038893 |
|||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Name : |
Mr. Sanjay Bhatia |
|||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||
|
Address : |
584, Model Town, Panipat – 132103, Haryana, India |
|||||||||||||||||||||||||||
|
Qualification : |
Graduate |
|||||||||||||||||||||||||||
|
Date of Appointment : |
16.04.1990 |
|||||||||||||||||||||||||||
|
PAN No.: |
ABQPB8286L |
|||||||||||||||||||||||||||
|
DIN No.: |
00189247 |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Name : |
Mrs. Anita Bhatia |
|||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||
|
Address : |
197, Model Town, Panipat – 132103, Haryana, India |
|||||||||||||||||||||||||||
|
Date of Appointment : |
01.04.2005 |
|||||||||||||||||||||||||||
|
PAN No.: |
ADAPB0176H |
|||||||||||||||||||||||||||
|
DIN No.: |
00038907 |
|||||||||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on: 22.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
Ajay Bhatia |
|
585390 |
|
Sanjay Bhatia |
|
656240 |
|
Anita Bhatia |
|
562276 |
|
Alka Bhatia |
|
270790 |
|
Aditya Bhatia |
|
1086072 |
|
Sanjeev Bhatia (HUF) |
|
520000 |
|
Nutan Bhatia |
|
181350 |
|
Kanta Bhatia |
|
201604 |
|
Parag Bhatia |
|
180362 |
|
Garima Bhatia |
|
92612 |
|
|
|
|
|
Total |
|
4336696 |
Equity Share Break up (Percentage of Total Equity)
As on: 22.09.2012
|
Category |
|
Percentage |
|
Directors or relatives of directors |
|
100.00 |
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and
Exporter of Pharmaceutical Formulations |
||||
|
|
|
||||
|
Products : |
|
PRODUCTION STATUS (As on 31.03.2010)
|
Particulars |
Licensed Capacity |
Installed Capacity (Quantity in dosage units in lacs on three shifts
basis |
|
|
|
|
|
Tablets |
Not Applicable |
57000 |
|
Capsules |
Not Applicable |
12600 |
|
Ointment |
Not Applicable |
1000 |
|
Injectables |
Not Applicable |
2915 |
|
Eye/ear drops |
Not Applicable |
1700 |
|
Oral Syrup |
Not Applicable |
720 |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Bankers : |
· Punjab National Bank, IBB, Palika Bazar, G.T. Road,, Panipat - 132103, Haryana, India · Bank of India, G T Road, Panipat – 132101, Haryana, India ·
State Bank of India, Taruwala, Haryana, India · HDFC Bank Limited |
||||||||||||
|
|
|
||||||||||||
|
Facilities : |
(Rs.
In Millions)
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Vinod Bhatia and Company Chartered Accountants |
|
Address : |
Green House, Opposite Sector-25, |
|
Tel. No.: |
91-180-2663800/ 2664800 |
|
PAN No.: |
AAEPB3230B |
CAPITAL STRUCTURE
As on: 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000000 |
Equity Shares |
Rs.10/- each |
Rs.50.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
4336696 |
Equity Shares |
Rs.10/- each |
Rs.43.367 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
43.367 |
43.367 |
16.680 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
588.251 |
521.236 |
483.893 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
631.618 |
564.603 |
500.573 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
381.729 |
402.857 |
338.581 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
106.254 |
|
|
TOTAL BORROWING |
381.729 |
402.857 |
444.835 |
|
|
DEFERRED TAX LIABILITIES |
3.760 |
3.761 |
2.948 |
|
|
|
|
|
|
|
|
TOTAL |
1017.107 |
971.221 |
948.356 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
321.737 |
343.710 |
330.158 |
|
|
Capital work-in-progress |
11.810 |
4.884 |
0.000 |
|
|
Expenditure pending allocation |
0.000 |
0.000 |
1.146 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.200 |
0.200 |
0.200 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
792.975
|
895.921 |
757.585
|
|
|
Sundry Debtors |
702.778
|
571.172 |
381.230
|
|
|
Cash & Bank Balances |
12.061
|
13.870 |
20.535
|
|
|
Other Current Assets |
1.538
|
1.794 |
0.000
|
|
|
Loans & Advances |
59.695
|
63.875 |
47.219
|
|
Total
Current Assets |
1569.047
|
1546.632 |
1206.569 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
594.171
|
648.474 |
557.417
|
|
|
Other Current Liabilities |
282.493
|
267.277 |
12.819
|
|
|
Provisions |
9.023
|
8.454 |
21.029
|
|
Total
Current Liabilities |
885.687
|
924.205 |
591.265 |
|
|
Net Current Assets |
683.360
|
622.427 |
615.304
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
1.548 |
|
|
|
|
|
|
|
|
TOTAL |
1017.107 |
971.221 |
948.356 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
2398.328 |
2167.108 |
1874.814 |
|
|
|
Other Income |
1.789 |
0.921 |
59.072 |
|
|
|
TOTAL (A) |
2400.117 |
2168.029 |
1933.886 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of materials consumed |
1712.819 |
1626.683 |
|
|
|
|
Purchases of stock-in-trade |
28.655 |
26.876 |
|
|
|
|
Changes in inventories of finished goods, work-in-progress and
stock-in-trade |
13.846 |
(66.266) |
|
|
|
|
Employee benefit expense |
81.092 |
79.289 |
|
|
|
|
Other expenses |
345.527 |
296.410 |
|
|
|
|
TOTAL (B) |
2181.939 |
1962.992 |
1748.543 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
218.178 |
205.037 |
185.343 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
65.449 |
62.406 |
30.857 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
152.729 |
142.631 |
154.486 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
43.450 |
42.081 |
19.339 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
109.279 |
100.550 |
135.147 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
22.105 |
20.959 |
27.255 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
87.174 |
79.591 |
107.892 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
471.396 |
437.365 |
357.850 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
NA |
45.560 |
28.377 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
NA |
471.396 |
437.365 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
NA |
NA |
425.030 |
|
|
TOTAL EARNINGS |
NA |
NA |
425.030 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
26.413 |
9.369 |
10.315 |
|
|
|
Plant and Machinery |
0.000 |
0.000 |
1.059 |
|
|
|
Capital Goods |
3.581 |
0.000 |
0.000 |
|
|
TOTAL IMPORTS |
29.994 |
9.369 |
11.374 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
20.10 |
18.35 |
64.69 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
3.63 |
3.67
|
5.75
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
4.56 |
4.64
|
7.21
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.78 |
5.32
|
8.79
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.17 |
0.15
|
0.27
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.60 |
0.71
|
0.89
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.77 |
1.67
|
2.04
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact person |
No |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
-- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
Yes |
CORPORATE
OVERVIEW:
During the year, the Company registered revenue growth in lines with the market performance. Production at all three plants remained in full swing throughout the year.
DOMESTIC OPERATIONS:
Along with widening their product baskets, the marketing division of the Domestic marketing has fast expended their base to almost all States of India. As on date the domestic operations are present in Northern, Southern, Eastern and Western India with a 200 strong field force, focused on Generic and ethical and generating volumes for the company’s innovative products.
Bankers Charges
Report as per Registry
|
Corporate identity
number (CIN) or foreign company registration number of the company |
U24239HR1990PLC030835 |
|
Name of the
company |
LABORATE
PHARMACEUTICALS INDIA LIMITED |
|
Address of the
registered office or of the principal place of business in India of the company |
E-11
Industrial Area, Panipat, Haryana –
132103, India Email-id - dkgc2004@yahoo.com |
|
This form is for |
Modification
of charge |
|
Charge
identification (ID) number of the charge to be modified |
80025558 |
|
Type of charge |
·
Immovable
property · Any interest in immovable property ·
Book
debts ·
Others
(All types of stocks and machineries) |
|
Particular of
charge holder |
Punjab National
Bank, IBB, Palika Bazar, G.T. Road, Panipat – 132103, Haryana, India Email-id -
bo4189@pnb.co.in |
|
Nature of
instrument creating charge |
Packing Credit
Agreement Hypothecation of
goods and book debts to secure cash credit facility Hypothecation of
movable assets forming part of block assets Packing Credit
Agreement Letter of Continuity |
|
Date of
instrument Creating the charge |
24.01.2013 |
|
Amount secured by
the charge |
Rs. 590.000
Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of Interest On Cc-Interest @ 1.50%
Spread Over The Prevailing Base Rate (Presently Being 10.50%) of The Bank I.E
@12.00% Per Annum With Monthly Rests. On Packing Credit
- @11.25% (Br+0.75%) Per Annum Terms of Repayment Cash Credit -
Repayable On Demand Margin 25% Extent and Operation of the charge First And
Exclusive Charge On All The Assets Of The Company |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
(i) RTD
5287/1 DT 09.11.2000 (ii) RTD
944/09 DT 11.08.2009 RTD 1476/09 DT 30.11.2009 (iii) RTD
849/1 DT 07.07.2004 (iv)
Hypothecation of All The Unencumbered Movable Assets Purchased or To Be
Purchased By The Company (v) Various Raw Materials
Viz. Manufacturing Material, Raw Materials Including Excisable Raw Materials,
Stocks In Process, Semi Finished Goods( Including Bought Out Finished Goods) (vi) Book Debts,
Outstanding Decrees, Money Receivables. Government Subsidies, Claims, Bill
Contracts And Investments, etc. |
|
Particulars of
the present modification |
Total Exposure To
The Company Is- Cash Credit
(HYP.) Rs.300.000 Millions Packing Credit
Rs. 180.000 Millions FOBP/ FOUBP/
FOBNLC/ FOUBNLC Rs.1000 Millions Export Limit
Rs.180.000 Millions Ceiling Fund
Based Rs.480.000 Millions LC (DP/ DA)
Inland/Foreign Rs.80.000 Millions LG/ TLG Rs.80.000
Millions Ceiling Non Fund
Based Rs.80.000 Millions Term Loan
Rs.30.000 Millions Total Exposure
Reached Upto Rs.590.000 Millions |
FIXED ASSETS
Tangible Assets
· Land
· Buildings
· Factory Building
· Plant and Equipment
· Factory Equipments
· Furniture and Fixtures
· Vehicles
· Computer Equipments
AS PER WEB DETAILS:
MILESTONES
|
1985 |
Foundation stone for Mfg. facility at Panipat |
|
1985 - 1988 |
Served the Domestic market only |
|
1989 |
First formulation export to Germany commences. |
|
1991 |
Formulation export to Belgium. |
|
1994 |
Started contract manufacturing for Pharma majors like Medrel, Helm, Troge etc |
|
1996 |
Onward started exports to Congo, Nigeria, Ghana, Kenya, Uganda, Tanzania and other African Countries |
|
1998 |
Launched Operations in Indian Generic Market |
|
2002 |
ISO 9001 Certified Facility WHO GMP |
|
2004 |
MOH SRILANKA Approved |
|
2005 |
State of the art manufacturing plant for Liquid Injectable, Dry Injections, Opthalmics, Tablets, Capsules, External Preparations in the Valley of Paonta Sahib, Himachal Pradesh. |
|
2006-07 |
Ranked at First position in IPM as best value Growth Company. · Ranked 49th amongst top 50 companies in India. · Recorded 25% growth in total sales. |
|
2008 |
Plant for Ayurvedic Drugs and Cosmetics. |
|
2009 |
Ponta sahib plant is acclimated with who GMP New production facilities as per US FDA standards at nari wala ponta sahib for liquid injections, capsules, tablets, ointment, dry injection, eye drops, and ear drops |
AWARDS
EMERGING INDIA AWARD
2ND RUNNER UP received at London
Jointly conferred by- ICICI BANK LIMITED AND CNBC TV 18 and CRISIL LIMITED
UDYOG RATTAN AWARD
For outstanding contribution in industrial development of the country
Presented by- institute of economic studies (IES)
EXCELLENCE AWARD
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.50 |
|
|
1 |
Rs.86.01 |
|
Euro |
1 |
Rs.73.68 |
INFORMATION DETAILS
|
Report Prepared
by : |
VRN |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
54 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.